
Mirum Pharmaceuticals
Mirum Pharmaceuticals, Inc.: A US-based biopharmaceutical company specializing in cholestatic liver disease therapies.
- 196
- Public
Mirum Pharmaceuticals, Inc. is a US-based biopharmaceutical company dedicated to developing therapies for cholestatic liver diseases. The company's mission is to address the unmet needs of patients with rare liver conditions by creating transformative treatments. Mirum Pharmaceuticals focuses on providing innovative solutions that significantly improve the quality of life for patients and their families.
Mirum Pharmaceuticals has made significant strides in the field of liver disease treatment, earning recognition for its commitment to scientific innovation and patient care. The company’s therapies have shown promise in clinical trials, positioning Mirum as a leader in the biopharmaceutical industry. Their efforts have had a profound impact on the lives of those affected by cholestatic liver diseases, underscoring the company's dedication to making a remarkable difference.
Similar Companies

Intercept Pharmaceuticals

Catalyst Pharmaceuticals
catalystpharma.com

Galmed Pharmaceuticals
galmedpharma.com

Assertio Holdings

Enanta Pharmaceuticals
enanta.com

Bayer Pharmaceuticals
bayer.com

Karyopharm Therapeutics
karyopharm.com
Mirata Pharmaceuticals
Mira Oncology

Astria Therapeutics
astriatx.com

Genoa Pharmaceuticals

Tarsus Pharmaceuticals
tarsusrx.com

Lumos Pharma
lumos-pharma.com

Harmony Biosciences
Mithridion
Quick Facts
Who are Mirum Pharmaceuticals' competitors?
Companies similar to Mirum Pharmaceuticals include Intercept Pharmaceuticals, Catalyst Pharmaceuticals, Galmed Pharmaceuticals and Assertio Holdings.
When was Mirum Pharmaceuticals founded?
Mirum Pharmaceuticals was founded in 2018.
Where is Mirum Pharmaceuticals' headquarters located?
Mirum Pharmaceuticals' headquarters is located in Foster City, CA, US.
When was Mirum Pharmaceuticals' last funding round?
Mirum Pharmaceuticals' most recent funding round was for $275M (USD) in April 2023.
How much disclosed funding has Mirum Pharmaceuticals raised?
As of Apr 13, 2023, Mirum Pharmaceuticals has disclosed funding of $497M (USD). Undisclosed round amounts are excluded.
How many employees does Mirum Pharmaceuticals have?
Mirum Pharmaceuticals has 196 employees as of Feb 6, 2024.
Classification
- Customer
- Main Product
- Ticker
- MIRM
- SEC CIK
- 0001759425
- EIN
- 83-1281555
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research